114 related articles for article (PubMed ID: 1293253)
1. Serum levels of lipids and apolipoproteins in angiographically assessed coronary artery disease in Japanese patients.
Sawada Y; Kotake H; Hoshio A; Ogino K; Nawada T; Hisatome I; Fujimoto Y; Mashiba H
J Med; 1992; 23(6):433-42. PubMed ID: 1293253
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of lipids and apolipoproteins in angiographycally defined ischemic heart disease.
Shima K; Tanaka A; Ejiri N; Maezawa H
Bull Tokyo Med Dent Univ; 1985 Dec; 32(4):169-77. PubMed ID: 3865743
[TBL] [Abstract][Full Text] [Related]
3. Levels of serum lipids, apolipoproteins A-I and B and pseudocholinesterase activity and their discriminative values in patients with coronary by-pass operation.
Lehtonen A; Marniemi J; Inberg M; Maatela J; Alanen E; Niittymäki K
Atherosclerosis; 1986 Feb; 59(2):215-21. PubMed ID: 3083832
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of apolipoproteins A-I and B as markers of angiographically assessed coronary artery disease.
Marcovina S; Zoppo A; Graziani MS; Vassanelli C; Catapano AL
Ric Clin Lab; 1988; 18(4):319-28. PubMed ID: 3150125
[TBL] [Abstract][Full Text] [Related]
5. Metabolic risk factors in the normolipidemic male patients with angiographically defined coronary artery disease.
Fujiwara R; Kutsumi Y; Hayashi T; Kim SS; Misawa T; Tada H; Nishio H; Toyota K; Tamai T; Nakai T
Jpn Circ J; 1990 May; 54(5):493-500. PubMed ID: 2232113
[TBL] [Abstract][Full Text] [Related]
6. [Lipids and apolipoproteins in relation to the degree of coronary sclerosis].
Herrmann W; Hanf S; Schütz C; Lindhofer HG; Abe I; Strauss HJ; Schmidt H; Schaedel H; Reuter W
Z Gesamte Inn Med; 1986 Feb; 41(4):98-102. PubMed ID: 3705656
[TBL] [Abstract][Full Text] [Related]
7. [Serum lipids and apolipoproteins AI, B100, CI, CII, and CIII in 142 patients with coronary heart disease].
Liu BW; Shao MZ; Yuan HJ; Wu ZF; Zhang ZH; Fu MD; Zhang RJ; Fan P
Hua Xi Yi Ke Da Xue Xue Bao; 1989 Jun; 20(2):119-22. PubMed ID: 2512245
[TBL] [Abstract][Full Text] [Related]
8. Plasma lipids and apolipoproteins as discriminators for presence and severity of angiographically defined coronary artery disease.
Noma A; Yokosuka T; Kitamura K
Atherosclerosis; 1983 Oct; 49(1):1-7. PubMed ID: 6651909
[TBL] [Abstract][Full Text] [Related]
9. Triglyceride enriched lipoprotein particles correlate with the severity of coronary artery disease.
Koren E; Corder C; Mueller G; Centurion H; Hallum G; Fesmire J; McConathy WD; Alaupovic P
Atherosclerosis; 1996 Apr; 122(1):105-15. PubMed ID: 8724117
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of measurements of serum apolipoprotein A-I, A-II and B in hypertriglyceridemic male patients with and without coronary artery disease.
Kukita H; Hamada M; Hiwada K; Kokubu T
Atherosclerosis; 1985 May; 55(2):143-9. PubMed ID: 3924067
[TBL] [Abstract][Full Text] [Related]
11. [Relation of plasma glucose levels to serum lipids and apolipoproteins levels in middle and old age males].
Duan Y; Wu Z; Liu B
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Sep; 32(3):382-4. PubMed ID: 12536570
[TBL] [Abstract][Full Text] [Related]
12. Serum lipid pattern as severity indicator of angiographically assessed coronary artery disease.
Uccella R; Donnini P; Franzetti I; Gaiazzi M
Artery; 1993; 20(6):346-60. PubMed ID: 8010890
[TBL] [Abstract][Full Text] [Related]
13. [Determination of the usefulness of selected biochemical parameters for assessing the advanced atheromatous changes in human coronary arteries].
Bukowska H
Ann Acad Med Stetin; 1998; 44():29-43. PubMed ID: 9857530
[TBL] [Abstract][Full Text] [Related]
14. Risk factors in normolipidemic male patients with coronary artery disease in Japanese.
Sonoda M; Sakamoto K; Miyauchi T; Sanada J; Nakamura K; Arima T; Kuriyama M; Nagata K; Osame M; Miyahara K
Jpn Circ J; 1992 Aug; 56(8):829-36. PubMed ID: 1527895
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
Cubrilo-Turek M; Sertić J; Duraković Z
Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
[TBL] [Abstract][Full Text] [Related]
16. High density lipoprotein cholesterol and triglycerides as markers of angiographically assessed coronary artery disease.
Nikkilä M; Koivula T; Niemelä K; Sisto T
Br Heart J; 1990 Feb; 63(2):78-81. PubMed ID: 2317412
[TBL] [Abstract][Full Text] [Related]
17. Serum apolipoprotein A-I, A-II and B levels and their discriminative values in relatives of patients with coronary artery disease.
Kukita H; Hiwada K; Kokubu T
Atherosclerosis; 1984; 51(2-3):261-7. PubMed ID: 6430307
[TBL] [Abstract][Full Text] [Related]
18. Effects of hormone replacement therapy and hepatic lipase polymorphism on serum lipid profiles in postmenopausal Japanese women.
Somekawa Y; Umeki H; Kobayashi K; Tomura S; Aso T; Hamaguchi H
J Clin Endocrinol Metab; 2002 Oct; 87(10):4766-70. PubMed ID: 12364471
[TBL] [Abstract][Full Text] [Related]
19. Dyslipoproteinemia and coronary disease.
Raos V; Strujić BJ
Angiology; 2002; 53(5):557-62. PubMed ID: 12365863
[TBL] [Abstract][Full Text] [Related]
20. [Plasma levels of lipids, lipoproteins and apolipoproteins affected by endogenous testosterone].
Zhao S; Li X; Wang Z
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(3):299-301. PubMed ID: 10681765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
